JP2015517520A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517520A5
JP2015517520A5 JP2015512636A JP2015512636A JP2015517520A5 JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5 JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5
Authority
JP
Japan
Prior art keywords
composition
subject
cells
cell
brain injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512636A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517520A (ja
JP6134783B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030895 external-priority patent/WO2013172944A1/en
Publication of JP2015517520A publication Critical patent/JP2015517520A/ja
Publication of JP2015517520A5 publication Critical patent/JP2015517520A5/ja
Application granted granted Critical
Publication of JP6134783B2 publication Critical patent/JP6134783B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512636A 2012-05-16 2013-03-13 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 Active JP6134783B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261647893P 2012-05-16 2012-05-16
US61/647,893 2012-05-16
PCT/US2013/030895 WO2013172944A1 (en) 2012-05-16 2013-03-13 Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016184086A Division JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2015517520A JP2015517520A (ja) 2015-06-22
JP2015517520A5 true JP2015517520A5 (https=) 2015-10-29
JP6134783B2 JP6134783B2 (ja) 2017-05-24

Family

ID=48040424

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015512636A Active JP6134783B2 (ja) 2012-05-16 2013-03-13 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2016184086A Pending JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2018082259A Pending JP2018111733A (ja) 2012-05-16 2018-04-23 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2021038508A Pending JP2021098738A (ja) 2012-05-16 2021-03-10 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2023078339A Pending JP2023099213A (ja) 2012-05-16 2023-05-11 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2025030492A Pending JP2025098021A (ja) 2012-05-16 2025-02-27 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2016184086A Pending JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2018082259A Pending JP2018111733A (ja) 2012-05-16 2018-04-23 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2021038508A Pending JP2021098738A (ja) 2012-05-16 2021-03-10 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2023078339A Pending JP2023099213A (ja) 2012-05-16 2023-05-11 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2025030492A Pending JP2025098021A (ja) 2012-05-16 2025-02-27 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物

Country Status (7)

Country Link
US (4) US9828593B2 (https=)
EP (1) EP2849766B1 (https=)
JP (6) JP6134783B2 (https=)
CN (3) CN104519891B (https=)
AU (2) AU2013263417B2 (https=)
CA (1) CA2872188C (https=)
WO (1) WO2013172944A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104519891B (zh) * 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
HK1208371A1 (en) 2012-10-09 2016-03-04 桑比欧公司 Methods and compositions for treatment of retinal degeneration
US20170065638A1 (en) * 2014-02-10 2017-03-09 Cytori Therapeutics, Inc. Regenerative cell therapy for central nervous system (cns) disorders and ptsd
CA2981523A1 (en) * 2015-04-01 2016-10-06 Sanbio, Inc. Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
US10555972B2 (en) * 2016-02-26 2020-02-11 Innopeutics Corporation Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells
WO2017152035A1 (en) * 2016-03-03 2017-09-08 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
JP7220149B2 (ja) 2016-12-28 2023-02-09 サンバイオ,インコーポレイティド 細胞送達システム及びその動作方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
JP3886346B2 (ja) 2001-06-22 2007-02-28 サンバイオ,インコーポレイティド 骨髄間質細胞由来Schwann細胞を含む神経再生用医薬組成物
CN101584869B (zh) * 2002-02-06 2013-03-27 桑比欧公司 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法
EP1644026A4 (en) * 2003-06-12 2007-10-24 Ms Science Corp SIGMA LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RECREATION
CA2929754A1 (en) 2004-04-12 2005-10-27 Sanbio Inc. Cells exhibiting neuronal progenitor cell characteristics
AU2006220696B2 (en) 2005-03-07 2010-08-19 Sanbio, Inc. Use of neuronal precursor cells for treatment of central nervous system lesions
CN101008033A (zh) * 2006-01-27 2007-08-01 陈云 功能性中枢神经损伤诊断检测用基因芯片及其制造方法
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
JP5662147B2 (ja) * 2007-08-15 2015-01-28 サンバイオ,インコーポレイティド 神経変性を治療するための方法及び組成物
WO2009073178A1 (en) 2007-12-03 2009-06-11 Sanbio, Inc. Extracellular matrix from pluripotent cells
ES2787513T3 (es) 2007-12-03 2020-10-16 Sanbio Inc Métodos y composiciones para modular la diferenciación de células pluripotenciales
JP5746016B2 (ja) 2008-04-30 2015-07-08 サンバイオ,インコーポレイティド Dnaメチル化における改変を伴う神経再生細胞連邦政府の援助に関する申告適用なし
CA2832356C (en) 2011-04-06 2017-12-19 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
EP2744891B1 (en) 2011-08-19 2018-12-12 SanBio, Inc. Neurogenic and gliogenic factors and assays therefor
EP2806881A1 (en) 2012-01-27 2014-12-03 SanBio, Inc. Methods and compositions for modulating angiogenesis and vasculogenesis
CN104519891B (zh) * 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物

Similar Documents

Publication Publication Date Title
JP2015517520A5 (https=)
WO2015031654A3 (en) Systems, compositions, and methods for transplantation and treating conditions
WO2020047467A3 (en) Cardiac cell reprogramming with myocardin and ascl1
FI3186395T4 (fi) Kantasolujen siirto kantasoluihin kohdistuvan aineen ja immunoregulatorisen signaloinnin modulaation yhdistelmällä
MX2021003702A (es) Uso de importadores de sustrato para la exportación de oligosacáridos.
MX2016005824A (es) Metodo de cultivo celular.
WO2013013025A3 (en) Anti-cxcr4 antibodies and methods of use
SA522432139B1 (ar) بروتينات ربط متعددة الخصوصية لمعالجة السرطان
GB201315212D0 (en) Systems, compositions and methods for transplantation
WO2014089169A4 (en) Immunotherapy with binding agents
SG10201809146QA (en) Recombinant host cell engineered to overexpress helper proteins
JP2015131795A5 (https=)
WO2016081032A3 (en) Mesenchymal stem cells derived from induced pluripotent stem cells
EA201270713A1 (ru) Белки на основе фибронектина с каркасными доменами, которые связывают ил-23
AU2018253575A1 (en) Natural killer cells from placenta
Kelly et al. TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia
EA201790025A1 (ru) Создание банка мезенхимальных стромальных клеток из объединенных мононуклеарных клеток нескольких доноров костного мозга
WO2016063026A3 (en) Selective nav protein binders
EA201400401A1 (ru) Биокомпозит для регенерации поврежденных тканей и органов, набор для изготовления биокомпозита и способ лечения
JP2017536826A5 (https=)
ZA202100888B (en) Methods of preparing personalized blood vessels
MX374489B (es) Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma.
JP2017039729A5 (https=)
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
WO2015181831A3 (en) A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord